ACTIVE

Boehringer Ingelheim Veterinary Medicine Belgium NV

Financial year 2025 · Closed on 31/12/2025

Net result486,7 k €-35,3 %over 1 year

Equity5,6 M €+9,6 %over 1 year

Workforce17,9 ETP+6,5 %over 1 year

Identity

Source · BCE/KBO

Boehringer Ingelheim Veterinary Medicine Belgium NV is a Public limited company incorporated in 2012. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Evergem. It employs on average 17,9 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0842.800.336
Incorporation: 17/01/2012
Legal form: Public limited company
Registered office: Noorwegenstraat 4
9940 Evergem · FlandreSee on map
Contributed capital: 3 995 531,16 €
Latest accounts: 31/12/2025
Average workforce: 17,9 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology 21100Manufacture of basic pharmaceutical products 21100Manufacture of basic pharmaceutical products 21201Manufacture of pharmaceutical preparations 21201Manufacture of pharmaceutical preparations+6

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 14 filings

Trend over 14 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	–		–		–		–		–
EBITDA	581,2 k €	-43.6%	1 M €	+14.3%	902,5 k €	+31.8%	684,9 k €	-49.0%	1,3 M €
Operating result	382,9 k €	-42.7%	668,2 k €	+13.6%	588,1 k €	+314%	141,9 k €	-78.6%	662,4 k €
Net result	486,7 k €	-35.3%	752,1 k €	+15.8%	649,4 k €	+366%	139,4 k €	-78.8%	656,3 k €
Balance sheet
Equity	5,6 M €	+9.6%	5,1 M €	+17.4%	4,3 M €	+17.7%	3,7 M €	+3.9%	3,5 M €
Total assets	6,5 M €	+10.4%	5,9 M €	+9.7%	5,4 M €	+3.4%	5,2 M €	+24.1%	4,2 M €
Cash	–		–		–		–		–
Debts	941,3 k €	+15.5%	815 k €	-22.2%	1 M €	-31.2%	1,5 M €	+141%	632,9 k €
Other
Workforce	17,9 ETP	+6.5%	16,8 ETP	-0.6%	16,9 ETP	+14.2%	14,8 ETP	+17.5%	12,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 23 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Lukas Hauschild	Director01/05/2026 → 21/06/2029
Carla Ramon	Director01/04/2025 → 19/06/2031
Friedrich Kaess	Managing director21/01/2026 → 21/06/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Christoph Tautphäus	Director01/11/2025 → 01/05/2026
Larisa Nurkanovic	Director01/11/2025 → 09/03/2026
Sebastian Guijarro	Director06/04/2024 → 19/06/2031

Other companies at this address

Noorwegenstraat 4 9940 Evergem

Company	CBE no.
ANABIOTEC● Active	0466.037.587
ERGO TUA RURA MANEBUNT● Active	0826.447.720
Group Nuytinck● Active	0538.554.193
HONESTUM PETIMUS USQUE● Active	0782.425.853
LABORATORIUM M. NUYTINCK● Active	0427.563.924
LABO VOOR KLINISCHE BIOLOGIE● Active	0451.023.967
MENTANA DX● Active	0786.290.908
NEC TEMERE, NEC TIMIDE● Active	0787.880.718
OHMX.bio● Active	0720.593.006
POST VERBA VERBERA● Active	0463.762.641

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	12/08/2025	26/06/2024	22/05/2023	25/07/2022	16/07/2021
General meeting	26/06/2026	31/07/2025	20/06/2024	27/04/2023	07/07/2022	17/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	26/06/2026	29/06/2026	Dutch	PDF
Full model	31/12/2024	31/07/2025	12/08/2025	Dutch	PDF
Full model	31/12/2023	20/06/2024	26/06/2024	Dutch	PDF
Full model	31/12/2022	27/04/2023	22/05/2023	Dutch	PDF
Full model	31/12/2021	07/07/2022	25/07/2022	Dutch	PDF
Abridged model	31/12/2020	17/06/2021	16/07/2021	Dutch	PDF
Abridged model	31/12/2019	18/06/2020	24/07/2020	Dutch	PDF
Abridged model	31/12/2018	20/06/2019	09/07/2019	Dutch	PDF
Abridged model	31/12/2017	16/04/2018	29/05/2018	Dutch	PDF
Abridged model	31/12/2016	07/07/2017	30/08/2017	Dutch	PDF
Abridged model	31/12/2015	30/04/2016	30/05/2016	Dutch	PDF
Abridged model	31/12/2014	18/06/2015	31/07/2015	Dutch	PDF
Abridged model	31/12/2013	19/06/2014	20/08/2014	Dutch	PDF
Abridged model	31/12/2012	20/06/2013	10/07/2013	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 23 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Lukas Hauschild	Director01/05/2026 → 21/06/2029
Carla Ramon	Director01/04/2025 → 19/06/2031
Friedrich Kaess	Managing director21/01/2026 → 21/06/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Christoph Tautphäus	Director01/11/2025 → 01/05/2026
Larisa Nurkanovic	Director01/11/2025 → 09/03/2026
Sebastian Guijarro	Director06/04/2024 → 19/06/2031

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates22/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Other16/04/2026
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates09/04/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/02/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other18/11/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates27/09/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/05/2024
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings14 filings

Mandates

Lukas Hauschild

Carla Ramon

Friedrich Kaess

Christoph Tautphäus

Larisa Nurkanovic

Sebastian Guijarro

Chiedza Kaitano

Eva Porta Soldevila

Mechtild Görke

Silke Seeber

Fatoumata Sow

Dana Leskova

and 11 more mandates

20122013201420152016201720182019202020212022202320242025202620272028202920302031

Boehringer Ingelheim Veterinary Medicine Belgium NV

Noorwegenstraat 4, 9940 Evergem

Director

Managing director

Director

Managing director

DirectorManaging director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Noorwegenstraat 4, 9940 EvergemCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00235177

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Boehringer Ingelheim Veterinary Medicine Belgium NVCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00235177

Events

2025
Annual accounts 2025486,7 k €↓
2024
Annual accounts 2024752,1 k €↑
2023
Annual accounts 2023649,4 k €↑
2022
Annual accounts 2022139,4 k €↓
2021
Annual accounts 2021656,3 k €↑
2020
Annual accounts 2020-1,3 M €↑
2019
Annual accounts 2019-2,6 M €↓
2018
Annual accounts 2018-811,3 k €↓
2017
Annual accounts 2017-347,3 k €↓
2016
Annual accounts 2016-95 k €↑
2015
Annual accounts 2015-484,6 k €↓
2014
Annual accounts 2014181,7 k €↓
2013
Annual accounts 2013201,2 k €↑
2012
Annual accounts 2012161,3 k €
17/01/2012
IncorporationPublic limited company

Boehringer Ingelheim Veterinary Medicine Belgium NV

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events